OpportunityTitle: Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Description: Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications that include investigator-initiated clinical trials related to the programmatic interests of the NCI Division of Cancer Prevention and the NCI Division of Cancer Control and Population Sciences as based on their scientific missions. Applications for clinical trials submitted under this FOA should be hypothesis-driven, have clearly described aims and objectives, and have the potential to reduce the burden of cancer through improvements in knowledge, early detection and diagnosis, prevention, healthcare delivery, quality of life, and/or survivorship related to cancer; with such attributes, the proposed studies should also have the potential to positively impact clinical practice and/or public health.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster &lt;br/&gt;FBOWebmaster@OD.NIH.GOV